🔗 Share this article

This year's prestigious award in Physiology or Medicine was granted for transformative findings that illuminate how the body's defense network attacks harmful infections while protecting the body's own cells.

A trio of renowned researchers—from Japan Prof. Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—received this accolade.

Their research identified unique "sentinels" within the immune system that eliminate rogue immune cells capable of attacking the body.

These findings are now paving the way for new treatments for immune disorders and malignancies.

These winners will divide a monetary award valued at 11m SEK.

Crucial Findings

"Their research has been decisive for understanding how the immune system functions and why we do not all suffer from severe autoimmune diseases," commented the head of the award panel.

This team's research explain a fundamental question: How does the defense system defend us from numerous infections while keeping our healthy cells intact?

The body's protection system employs immune cells that search for signs of disease, even pathogens and germs it has not met before.

Such defenders employ detectors—known as recognition units—that are generated by chance in a vast number of combinations.

This gives the defense network the capacity to fight a wide array of invaders, but the randomness of the mechanism unavoidably produces immune cells that can target the host.

Protectors of the Immune System

Researchers earlier understood that some of these harmful white blood cells were destroyed in the immune organ—where immune cells mature.

This year's award honors the discovery of T-reg cells—described as the body's "peacekeepers"—which patrol the system to disarm any immune cells that attack the body's own tissues.

We know that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, MS, and rheumatoid arthritis.

The Nobel panel added, "The findings have established a new field of research and spurred the creation of innovative therapies, for instance for cancer and immune disorders."

Regarding malignancies, T-regs block the body from fighting the tumor, so studies are focused on lowering their numbers.

In self-attack disorders, experiments are testing boosting T-reg cells so the organism is not being harmed. A similar method could also be useful in minimizing the chances of organ transplant rejection.

Pioneering Experiments

Professor Sakaguchi, from a Japanese institution, performed tests on mice that had their thymus extracted, leading to autoimmune disease.

The researcher showed that introducing defense cells from other animals could prevent the disease—implying there was a mechanism for preventing defenders from harming the body.

Mary Brunkow, from the a research center in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in a California city, were studying an inherited immune disorder in rodents and people that led to the discovery of a gene vital for the way regulatory T-cells function.

"Their groundbreaking research has uncovered how the immune system is kept in check by regulatory T cells, stopping it from mistakenly targeting the healthy cells," said a leading biological science specialist.

"The work is a remarkable example of how basic biological study can have broad consequences for human health."